Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Autor:
Geller, Melissa A., Cooley, Sarah, Argenta, Peter A., Downs, Levi S., Carson, Linda F., Judson, Patricia L., Ghebre, Rahel, Weigel, Brenda, Panoskaltsis-Mortari, Angela, Curtsinger, Julie, Miller, Jeffrey S.
Publikováno v:
Cancer Immunology, Immunotherapy; Dec2010, Vol. 59 Issue 12, p1877-1884, 8p
Publikováno v:
Cancer Immunology, Immunotherapy
To examine the relationship between cytotoxic T lymphocyte antigen 4 (CTLA-4) expression and breast cancer prognosis, CTLA-4 expression was immunohistochemically detected in paraffin-embedded specimens of primary tumors from 130 patients with breast
Autor:
Mads Hald Andersen, Cathrin Ritter, Per thor Straten, Jürgen C. Becker, Rikke Sick Andersen, Inge Marie Svane, Rikke Bæk Sørensen
Publikováno v:
Cancer Immunology, Immunotherapy
With the aim to identify cyclin B1-derived peptides with high affinity for HLA-A2, we used three in silico prediction algorithms to screen the protein sequence for possible HLA-A2 binders. One peptide scored highest in all three algorithms, and the h
Autor:
Reiner Laus, Lisa Do, John R. Lombardo, Ulrike Dirmeier, Katie Dalpozzo, Alain Delcayre, Peter L. Schoonmaker, Ryan Rountree, Robin Steigerwald, Stefanie Mandl, Thierry Giffon
Publikováno v:
Cancer Immunology, Immunotherapy
MVA-BN®-HER2 is a new candidate immunotherapy designed for the treatment of HER-2-positive breast cancer. Here, we demonstrate that a single treatment with MVA-BN®-HER2 exerts potent anti-tumor efficacy in a murine model of experimental pulmonary m
Autor:
Asif A. Quadri, Salman M Toor, Jihad Kanbar, Eyad Elkord, Mohamed Albashir, Issam Faour, Haytham El Salhat, Azharuddin Sajid Syed Khaja
Publikováno v:
Elkord, E 2017, ' Myeloid cells in circulation and tumor microenvironment of breast cancer patients ', Cancer Immunology, Immunotherapy, vol. 66, no. 6, pp. 753-764 . https://doi.org/10.1007/s00262-017-1977-z
Cancer Immunology, Immunotherapy
Cancer Immunology, Immunotherapy
Pathological conditions including cancers lead to accumulation of a morphological mixture of highly immunosuppressive cells termed as myeloid-derived suppressor cells (MDSC). The lack of conclusive markers to identify human MDSC, due to their heterog